Efficacy and Safety of Polyene Phosphatidylcholine in Treatment of Patients With Acute Drug-induced Liver Injury

NCT04595916 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

73

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Drug Induced Liver Injury

Interventions

DRUG: Polyene phosphatidylcholine injection 930 mg QD
DRUG: Magnesium Isoglycyrrhizinate injection 200 mg QD

Sponsor

Sichuan Haisco Pharmaceutical Group Co., Ltd